Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
33.14 USD | +2.79% | -5.93% | -19.48% |
May. 23 | Arvinas, Inc. Announces Upcoming Presentations at the 2024 American Society of Clinical Oncology Annual Congress | CI |
May. 16 | Sector Update: Health Care Stocks Steady Premarket Thursday | MT |
Financials (USD)
Sales 2024 * | 182M | Sales 2025 * | 219M | Capitalization | 2.27B |
---|---|---|---|---|---|
Net income 2024 * | -256M | Net income 2025 * | -307M | EV / Sales 2024 * | 7.3 x |
Net cash position 2024 * | 936M | Net cash position 2025 * | 583M | EV / Sales 2025 * | 7.68 x |
P/E ratio 2024 * |
-8.81
x | P/E ratio 2025 * |
-7.38
x | Employees | 445 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 91.16% |
Latest transcript on Arvinas, Inc.
1 day | +2.79% | ||
1 week | -5.93% | ||
1 month | +4.31% | ||
3 months | -27.93% | ||
6 months | +50.84% | ||
Current year | -19.48% |
Managers | Title | Age | Since |
---|---|---|---|
John Houston
CEO | Chief Executive Officer | 64 | 16-12-31 |
Randy Teel
DFI | Director of Finance/CFO | 45 | 18-04-30 |
Lisa Sinclair
COO | Chief Operating Officer | - | 22-08-14 |
Members of the board | Title | Age | Since |
---|---|---|---|
Wendy Dixon
BRD | Director/Board Member | 68 | 20-06-28 |
John Young
BRD | Director/Board Member | 60 | 22-08-17 |
Leslie Norwalk
BRD | Director/Board Member | 58 | 19-07-23 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.23% | 25 M€ | -2.35% | - | |
0.21% | 0 M€ | 0.00% | - | |
0.15% | 0 M€ | 0.00% | - | |
0.11% | 430 M€ | -.--% |
Date | Price | Change | Volume |
---|---|---|---|
24-05-31 | 33.14 | +2.79% | 1,002,064 |
24-05-30 | 32.24 | -4.90% | 631,371 |
24-05-29 | 33.9 | -3.83% | 409,421 |
24-05-28 | 35.25 | +0.06% | 609,953 |
24-05-24 | 35.23 | -.--% | 480,978 |
Delayed Quote Nasdaq, May 31, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-19.48% | 2.27B | |
+11.91% | 118B | |
+11.60% | 106B | |
-4.68% | 24.28B | |
-0.82% | 21.96B | |
-10.12% | 18.16B | |
-42.12% | 16.37B | |
-17.47% | 15.56B | |
+2.77% | 13.63B | |
+34.58% | 12.27B |
- Stock Market
- Equities
- ARVN Stock